Nabil Elhadi Omar

14PUBLICATIONS
35CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Other literatures in EnglishCardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 10, 2026
Effect of RAS Pathway Gene Mutations on Survival in Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis.

Yasmin Eslalakawi, Mohamed Omar Saad, Amin S Sanosi

|Nov 26, 2025
Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma.

Nabil E Omar, Hazem Elewa, Kareem A El-Fass

|Oct 17, 2024
Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non-Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study.

Rawan Dawoud, Harman Saman, Kakil Rasul

|May 23, 2024
Global Landscape of the Attack of Predatory Journals in Oncology.

Khalid El Bairi, Dario Trapani, Sara Jamil Nidhamalddin

|Apr 17, 2023
Post-COVID-19-associated multiorgan complications or "long COVID" with literature review and management strategy discussion: A meta-analysis.

Phool Iqbal, Fateen Ata, Hassan Chaudhry

|Sep 06, 2022
COVID-19 Vaccination in Cancer Patients: A Review Article.

Rana Mekkawi, Bassant A Elkattan, Alaaeldin Shablak

Pageof 3

Frequent Collaborators

2 joint publications

Shereen Elazzazy

2 joint publications

Mohamed A Yassin

2 joint publications

Fateen Ata

1 joint publications

Monica Zolezzi